Literature DB >> 22777568

Cerebral microhemorrhage in Marchiafava-Bignami disease detected by susceptibility-weighted imaging.

Ryuta Kinno1, Masahiro Yamamoto, Takahiro Yamazaki, Yoshiyuki Owan, Toshiya Fukui, Eriko Kinugasa.   

Abstract

Marchiafava-Bignami disease (MBD) is a rare alcohol-associated disorder. Clinical features include not only disturbed consciousness, dysarthria, tetraparesis, astasia-abasia, and symptoms of interhemispheric disconnection as initial symptoms but also cognitive deficits as clinical outcomes. The clinical significance of cerebral microhemorrhage (CMH) has been recognized in patients with cognitive deficits; however, the presence of CMH in patients with MBD has not been emphasized. The aim of the present study was to clarify the relationship between CMH and MBD. For this purpose, we report four patients with MBD, who showed asymmetrical hypointense areas in multiple cortico-subcortical regions on susceptibility-weighted imaging (SWI). All cases had a history of chronic alcohol abuse and symmetrical lesions in the entire corpus callosum. These patients' clinical symptoms included not only coma, dysarthria, and astasia-abasia as initial symptoms but also dementia as a clinical outcome. SWI showed asymmetrical hypointense areas in the multiple cortico-subcortical regions, indicating the presence of CMH. Compared with patients with normal cognitive function, demented patients showed higher severity of CMH. Our report would indicate that CMH is an important factor indicating the severity of dementia in patients with MBD.

Entities:  

Mesh:

Year:  2012        PMID: 22777568     DOI: 10.1007/s10072-012-1147-1

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  9 in total

Review 1.  Clinicoradiologic subtypes of Marchiafava-Bignami disease.

Authors:  Alexander Heinrich; Uwe Runge; Alexander V Khaw
Journal:  J Neurol       Date:  2004-09       Impact factor: 4.849

2.  Comparison of 7.0-T T₂*-magnetic resonance imaging of cerebral bleeds in post-mortem brain sections of Alzheimer patients with their neuropathological correlates.

Authors:  J De Reuck; F Auger; C Cordonnier; V Deramecourt; N Durieux; F Pasquier; R Bordet; C A Maurage; D Leys
Journal:  Cerebrovasc Dis       Date:  2011-03-21       Impact factor: 2.762

Review 3.  Cerebral microhemorrhage.

Authors:  Anand Viswanathan; Hugues Chabriat
Journal:  Stroke       Date:  2006-01-05       Impact factor: 7.914

Review 4.  [Marchiafava-Bignami disease. Interhemispheric disconnection, favourable outcome, neurological aspect].

Authors:  S Canaple; A Rosa; J P Mizon
Journal:  Rev Neurol (Paris)       Date:  1992       Impact factor: 2.607

5.  An autopsy case of Marchiafava-Bignami disease with peculiar chronological CT changes in the corpus callosum: neuroradiopathological correlations.

Authors:  J Y Shiota; I Nakano; M Kawamura; K Hirayama
Journal:  J Neurol Sci       Date:  1996-03       Impact factor: 3.181

6.  Prevalence and severity of microbleeds in a memory clinic setting.

Authors:  C Cordonnier; W M van der Flier; J D Sluimer; D Leys; F Barkhof; P Scheltens
Journal:  Neurology       Date:  2006-05-09       Impact factor: 9.910

7.  The Wernicke-Korsakoff syndrome. A clinical and pathological study of 245 patients, 82 with post-mortem examinations.

Authors:  M Victor; R D Adams; G H Collins
Journal:  Contemp Neurol Ser       Date:  1971

Review 8.  The Korsakoff syndrome: clinical aspects, psychology and treatment.

Authors:  Michael D Kopelman; Allan D Thomson; Irene Guerrini; E Jane Marshall
Journal:  Alcohol Alcohol       Date:  2009-01-16       Impact factor: 2.826

Review 9.  Cerebral microbleeds: a guide to detection and interpretation.

Authors:  Steven M Greenberg; Meike W Vernooij; Charlotte Cordonnier; Anand Viswanathan; Rustam Al-Shahi Salman; Steven Warach; Lenore J Launer; Mark A Van Buchem; Monique Mb Breteler
Journal:  Lancet Neurol       Date:  2009-02       Impact factor: 44.182

  9 in total
  6 in total

1.  Corticosteroid treatment in a patient with Marchiafava-Bignami disease.

Authors:  A Consoli; D Pirritano; D Bosco; P Postorino; D Consoli
Journal:  Neurol Sci       Date:  2014-03-09       Impact factor: 3.307

Review 2.  Susceptibility-weighted imaging and quantitative susceptibility mapping in the brain.

Authors:  Chunlei Liu; Wei Li; Karen A Tong; Kristen W Yeom; Samuel Kuzminski
Journal:  J Magn Reson Imaging       Date:  2014-10-01       Impact factor: 4.813

3.  Partial interhemispheric disconnection syndrome (P-IHDS) secondary to Marchiafava-Bignami disease type B (MBD-B).

Authors:  Carlo Canepa; Lorena Arias
Journal:  BMJ Case Rep       Date:  2016-11-23

4.  Marchiafava-Bignami disease concurrent with intracerebral hemorrhage: a case description.

Authors:  Zhiwei Zhou; Qinghui Li; Ling Zeng; Tijiang Zhang; Ping Xu
Journal:  Quant Imaging Med Surg       Date:  2022-04

5.  Marchiafava-Bignami disease mimics motor neuron disease: case report.

Authors:  Yasunobu Hoshino; Yuji Ueno; Hideki Shimura; Nobukazu Miyamoto; Masao Watanabe; Nobutaka Hattori; Takao Urabe
Journal:  BMC Neurol       Date:  2013-12-21       Impact factor: 2.474

6.  Marchiafava-Bignami disease with rare etiology: A case report.

Authors:  Yongjian Cui; Lei Zheng; Xiaoli Wang; Weiwen Zhang; Dongcai Yuan; Yan Wei
Journal:  Exp Ther Med       Date:  2015-02-05       Impact factor: 2.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.